Mangoceuticals, Inc. (MGRX) earnings
MGRX earnings moved a median of -0.93% by the close. Quarterly and annual MGRX reports and results, each read against the price at its own news timestamp. Back to the MGRX overview →
15 measured MGRX earnings events.
Where these MGRX earnings landedvs 15 measured MGRX earnings reactions
| Middle 50% of MGRX earnings reactions | -6.28% to +0.67% |
|---|---|
| Median reaction (to close) | -0.93% |
| Measured reactions | 15 |
Point-in-time · zero look-ahead
Half of the 15 MGRX earnings events with a measured close landed between -6.28% and +0.67%; 33% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q MANGOCEUTICALS, INC. For: Jun 30 | SEC filing · Form 10-Q | +0.45% | -8.56% | |
| Form 10-Q MANGOCEUTICALS, INC. For: Mar 31 | SEC filing · Form 10-Q | -2.12% | +4.15% | |
| Form NT 10-Q MANGOCEUTICALS, INC. For: Mar 31 | SEC filing · Form NT | +0.95% | -3.80% | |
| Form 10-K MANGOCEUTICALS, INC. For: Dec 31 | SEC filing · Form 10-K | +2.08% | +0.00% | |
| Form NT 10-K MANGOCEUTICALS, INC. For: Dec 31 | SEC filing · Form NT | +2.08% | +0.00% | |
| Form 10-Q MANGOCEUTICALS, INC. For: Sep 30 | SEC filing · Form 10-Q | -3.31% | -7.35% | |
| Form 10-Q/A MANGOCEUTICALS, INC. For: Jun 30 | SEC filing · Form 10-Q | -3.31% | -7.35% | |
| Form 10-Q MANGOCEUTICALS, INC. For: Jun 30 | SEC filing · Form 10-Q | -2.31% | -5.20% | |
| Form 10-Q MANGOCEUTICALS, INC. For: Mar 31 | SEC filing · Form 10-Q | +0.74% | +8.89% | |
| Form 10-K MANGOCEUTICALS, INC. For: Dec 31 | SEC filing · Form 10-K | +3.68% | +3.00% | |
| Form 10-Q MANGOCEUTICALS, INC. For: Sep 30 | SEC filing · Form 10-Q | -1.24% | -4.54% | |
| Form 10-Q MANGOCEUTICALS, INC. For: Jun 30 | SEC filing · Form 10-Q | -5.39% | -0.93% | |
| Form 10-Q MANGOCEUTICALS, INC. For: Mar 31 | SEC filing · Form 10-Q | -3.09% | +0.09% | |
| Form 10-K MANGOCEUTICALS, INC. For: Dec 31 | SEC filing · Form 10-K | — | +1.25% | |
| Form 10-Q MANGOCEUTICALS, INC. For: Sep 30 | SEC filing · Form 10-Q | +6.30% | -8.86% |
Keep exploring
More MGRX: analyst actions → · SEC filings → · MGRX overview →